Tag: Collaboration

AbCellera Announces Therapeutic Antibody Discovery Collaboration with Gilead

AbCellera, a leader in therapeutic antibody discovery from natural immune systems, announced it has entered into an agreement with Gilead Sciences to support the discovery of therapeutic antibody cand...

3P Biopharmaceuticals and Affibody in Collaboration Agreement

The arrangement covers process transfer, process development and GMP manufacture of affibody’s candidate. 3P Biopharmaceuticals, a leading CDMO specialized in the process development and GMP manufa...

Merck Signed Joint Development Agreement with Rigaku

Rigaku Corporation, a key player in scientific analytical instrumentation, and Merck KGaA, Darmstadt, Germany, a leading science and technology company, have signed a joint development agreement. T...

Abveris and TetraGenetics in Discover Antibodies Collaboration

Abveris, Inc., a leader in contract research antibody discovery, announced that it has entered into a multi-target agreement with TetraGenetics, Inc. a biopharmaceutical company developing novel antib...

Bayer and Foundation Medicine to Develop NSG-based Companion Diagnostics

bayer
Bayer AG and Foundation Medicine, Inc. announced a global collaboration for the development and commercialization of NGS-based companion diagnostics. This agreement allows for collaboration across ...

Genentech and Parvus in Worldwide Collaboration

Parvus Therapeutics, a biopharmaceutical company focused on the development of disease-specific immunoregulatory medicines to treat autoimmune diseases without impairing normal immunity, has entered i...

Gilead and insitro Partners in NASH Field

Gilead Sciences Inc. and insitro announced that the companies have entered into a strategic collaboration to discover and develop therapies for patients with nonalcoholic steatohepatitis (NASH). Un...

AbCellera to Initiate Global Health Research

AbCellera announced a two-year agreement with the Bill & Melinda Gates Foundation to help accelerate global health research. The funding, totaling $4.8 M, will support a series of scientific colla...

Ukrainian and Danish Drug Discovery Alliance

Enamine Ltd. a provider of integrated drug discovery services empowered by the world’s largest collections of building blocks and screening compounds, and H. Lundbeck A/S (Lundbeck), the global pharma...

Lilly and ImmuNext in Research Collaboration

Eli Lilly and Company and ImmuNext, Inc. announced a global licensing and research collaboration focused on the study of a preclinical novel target that could lead to potential new medicines for autoi...

HitGen and Almirall to Discover Novel Leads

HitGen Ltd announced that the company has entered into a research collaboration with Almirall to identify novel small molecule leads for targets of interest. In this collaboration, HitGen will apply i...

LCB Partners with Takeda in Immuno-Oncology Field

LegoChem Biosciences, Inc. (LCB) announced that it has entered a research collaboration and license agreement with Takeda Pharmaceutical Company Limited (“Takeda”) for the development of antibody-drug...

LG Chem and PDC*line to Develop New Class of Antigen

PDC*line Pharma, a biotech company developing a new class of potent and scalable antigen presenting cell, based on a proprietary cell line of Plasmacytoid Dendritic cells (PDC*line), announces that it...

Zealand and Alexion to Develop Novel Peptide Therapy

Collaboration further strengthens Zealand Pharma’s position as a leading developer of next generation peptide-based therapeutics.  Alexion Pharmaceuticals, Inc. and Zealand Pharma A/S announced a c...

Alexion and Affibody Partner to Develop Rare Disease Treatment

Alexion
Alexion Pharmaceuticals, Inc. and Affibody AB announced a partnership to co-develop ABY-039 for rare Immunoglobulin G (IgG)-mediated autoimmune diseases. Currently in Phase 1 development, ABY-039 is a...

Celgene Partners with AI Drug Discovery Company

Exscientia, a world-leading Artificial Intelligence (AI)-driven drug discovery company, announced today that it has entered a three-year AI drug discovery partnership with leading biopharma company Ce...